E. Moorahrend

Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

S. Al-Batran, T. Goetze, S. Hegewisch‐Becker, 2020, The oncologist.

Myelodysplastic syndromes (MDS) in regular care in Germany – the oldest patients come to the fore

B. Lathan, H. Tesch, U. Germing, 2018, Leukemia & lymphoma.

Trastuzumab (TRA) in combination with different first-line chemotherapies for treatment of HER2-positive metastatic gastric or gastroesophageal junction cancer (MGC): Findings from the German noninterventional observational study HerMES.

V. Kaechele, S. Al-Batran, V. Petersen, 2012 .

642PTRASTUZUMAB IN COMBINATION WITH DIFFERENT FIRST-LINE CHEMOTHERAPIES FOR TREATMENT OF HER2-POSITIVE METASTATIC GASTRIC CANCER: UPDATED FINDINGS FROM THE GERMAN NON-INTERVENTIONAL STUDY HERMES.

V. Petersen, S. Hegewisch‐Becker, P. Thuss-Patience, 2014, Annals of Oncology.

Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real‐world data from the noninterventional TACTIC study in Germany

T. Decker, F. Hartmann, M. Welslau, 2023, International journal of cancer.

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)

C. Kortsik, T. Trarbach, W. Brueckl, 2023, JTO clinical and research reports.